Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in ...

When John Ebers was diagnosed with Stage 3 colorectal cancer, he was not given the option of genetic testing, which could ...

The FDA approved a new targeted therapy called Lyrfigtu (lirafugratinib) on September 23, 2026, for a specific type of bile ...

Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.

The FDA has approved a new pill for one of the most common forms of pancreatic cancer. What to know about managing the financial impact of a cancer diagnosis.

When an ad for a new cancer drug pops up in your newsfeed, it might look like an overnight success. But even developing a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted treatment for pancreatic cancer has been approved by the FDA after impressive ...

The Food and Drug Administration on Friday approved a new, targeted breast cancer drug for patients who become resistant to hormone therapy.

The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer.

Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy ...

The typical price for a newly approved prescription drug has surpassed $250,000, a new study shows, reflecting rising costs for insurers, patients.

Advanced therapies have not been linked to clearly different cancer risks in patients with rheumatoid arthritis and prior ...